当前位置: 首页 > 期刊 > 《上海医药》 > 2014年第1期 > 正文
编号:12708527
治疗难辨梭菌感染的新18元大环内酯抗生素非达霉素(4)
http://www.100md.com 2014年1月1日 黄仲义 黄嘉骅 赵永红
第1页

    参见附件。

     [11] Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity [J]. Clin Infect Dis, 2007, 45(3): 302-307.

    [12] Treatment News. Optimer Pharmaceuticals receives orphan drug designation for fidaxomicin for the treatment of pediatric Clostridium difficile infection [EB/OL]. (2011-01-12) [2013-12-13]. http://www.checkorphan.org/grid/news/treatment/optimer-pharmaceuticals-receives-orphan-drug-designation-for-fidaxomicin-for-the-treatment-of-pediatric-clostridium-difficile-infection ......

您现在查看是摘要介绍页,详见PDF附件